Nucleic acid amplification
AssigneeCommonwealth Scientific and Industrial Research Organisation
InventorKeith Norman Rand
Life of this patent
Estimating the term…
Loading patent…
AssigneeCommonwealth Scientific and Industrial Research Organisation
InventorKeith Norman Rand
Estimating the term…
Provided herein is a method for the selective amplification of a target nucleotide sequence located within a nucleic acid molecule, the method comprising contacting the nucleic acid molecule (“template” molecule) with (i) at least one facilitator oligonucleotide, wherein the facilitator oligonucleotide includes at least one modification at or near its 3′ terminus such that 3′ extension from the facilitator oligonucleotide is blocked, and (ii) two or more oligonucleotide primers, at least one of which is an initiator primer modified such that the presence of the modification prematurely terminates complementary strand synthesis, wherein the facilitator oligonucleotide and the initiator primer bind to substantially the same or adjacent regions of the template nucleic acid molecule and the facilitator oligonucleotide further comprises sequences complementary to the target sequence 3′ to the binding location of the initiator primer; and carrying out thermocyclic, enzymatic amplification such that the specific target sequence is selectively amplified.
A method for the selective amplification of a target nucleotide sequence located within a nucleic acid molecule, the method comprising:
(canceled)
(canceled)
(canceled)
(canceled)
A method for improving the specificity of a thermocyclic enzymatic amplification reaction, the reaction utilizing at least two oligonucleotide primers flanking a target nucleotide sequence of interest located within a nucleic acid molecule, wherein at least one of said primers is modified such that the presence of the modification prematurely terminates complementary strand synthesis and the reaction further utilizes at least one non-priming facilitator oligonucleotide, wherein the facilitator oligonucleotide includes at least one modification at or near its 3′ terminus such that 3′ extension from the facilitator oligonucleotide is blocked, and wherein the facilitator oligonucleotide and the modified primer bind to substantially the same or adjacent regions of the template nucleic acid molecule and the facilitator oligonucleotide further comprises sequences complementary to the target sequence 3′ to the binding location of the modified primer.
A method for detecting a variant nucleotide sequence, the method comprising selectively amplifying a target nucleotide sequence located within a nucleic acid molecule and comprising the variant sequence, wherein the method comprises:
26-28. (canceled)
Dependencies are inferred from the claim text.